Aspen Aerogels (NYSE:ASPN) Stock Price Down 6.8% – What’s Next?

Aspen Aerogels, Inc. (NYSE:ASPN) fell 6.8% during trading on Thursday . The company traded as low as $23.25 and last traded at $23.69. 1,531,674 shares were traded during mid-day trading, an increase of 8% from the average session volume of 1,411,715 shares. The stock had previously closed at $25.41.

Analysts Set New Price Targets

ASPN has been the subject of a number of recent research reports. Roth Mkm reaffirmed a “buy” rating and set a $36.00 price target on shares of Aspen Aerogels in a research note on Wednesday, August 21st. HC Wainwright reissued a “buy” rating and issued a $30.00 target price on shares of Aspen Aerogels in a research report on Wednesday. TD Cowen raised their price target on shares of Aspen Aerogels from $36.00 to $41.00 and gave the company a “buy” rating in a report on Tuesday, August 20th. B. Riley upgraded shares of Aspen Aerogels to a “strong-buy” rating in a report on Tuesday, June 25th. Finally, Barclays assumed coverage on Aspen Aerogels in a report on Tuesday, August 6th. They set an “overweight” rating and a $27.00 target price on the stock. One research analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, Aspen Aerogels has an average rating of “Moderate Buy” and an average target price of $29.70.

Aspen Aerogels Price Performance

The company has a quick ratio of 2.82, a current ratio of 3.46 and a debt-to-equity ratio of 0.23. The stock’s 50-day moving average price is $26.00 and its 200 day moving average price is $24.35. The firm has a market cap of $1.65 billion, a price-to-earnings ratio of -49.08 and a beta of 2.16.

Aspen Aerogels (NYSE:ASPN) last released its quarterly earnings data on Wednesday, August 7th. The construction company reported $0.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.05 by $0.16. The business had revenue of $117.80 million for the quarter, compared to analysts’ expectations of $101.99 million. Aspen Aerogels had a return on equity of 0.74% and a net margin of 0.39%. Aspen Aerogels’s quarterly revenue was up 144.4% on a year-over-year basis. During the same period in the previous year, the business posted ($0.22) earnings per share. Equities research analysts predict that Aspen Aerogels, Inc. will post 0.21 earnings per share for the current year.

Insider Buying and Selling

In other news, CEO Donald R. Young sold 63,355 shares of the stock in a transaction that occurred on Monday, September 30th. The stock was sold at an average price of $30.03, for a total value of $1,902,550.65. Following the completion of the transaction, the chief executive officer now directly owns 483,640 shares of the company’s stock, valued at approximately $14,523,709.20. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other Aspen Aerogels news, CEO Donald R. Young sold 63,355 shares of the business’s stock in a transaction dated Monday, September 30th. The shares were sold at an average price of $30.03, for a total value of $1,902,550.65. Following the transaction, the chief executive officer now directly owns 483,640 shares in the company, valued at $14,523,709.20. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Ricardo C. Rodriguez sold 32,465 shares of Aspen Aerogels stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $30.14, for a total transaction of $978,495.10. Following the completion of the transaction, the chief financial officer now owns 20,790 shares of the company’s stock, valued at $626,610.60. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 4.30% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. boosted its position in Aspen Aerogels by 5.1% in the 1st quarter. Vanguard Group Inc. now owns 3,619,702 shares of the construction company’s stock valued at $63,707,000 after buying an additional 175,906 shares during the last quarter. Hood River Capital Management LLC increased its position in Aspen Aerogels by 12.2% in the first quarter. Hood River Capital Management LLC now owns 3,300,443 shares of the construction company’s stock worth $58,088,000 after purchasing an additional 357,895 shares during the period. Driehaus Capital Management LLC raised its holdings in Aspen Aerogels by 130.4% during the 2nd quarter. Driehaus Capital Management LLC now owns 2,156,789 shares of the construction company’s stock worth $51,439,000 after purchasing an additional 1,220,724 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in Aspen Aerogels by 21.3% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,374,631 shares of the construction company’s stock valued at $32,790,000 after purchasing an additional 240,921 shares during the period. Finally, American Century Companies Inc. boosted its stake in shares of Aspen Aerogels by 562.3% in the 2nd quarter. American Century Companies Inc. now owns 770,729 shares of the construction company’s stock valued at $18,382,000 after purchasing an additional 654,350 shares during the last quarter. 97.64% of the stock is owned by institutional investors.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.